MedPath

Rhythm Control of AF in Patients With Acute Stroke

Not Applicable
Conditions
Atrial Fibrillation
Registration Number
NCT02285387
Lead Sponsor
Yonsei University
Brief Summary

Prospective randomized (rhythm control or rate control) Objective of study

1. To analyze long term outcome of patients with acute stroke with atrial fibrillation according to the rhythm control

2. To analyze recurrence rate of atrial fibrillation or recurrence stroke in patients with acute stroke according to the rhythm control (by antiarrhythmic drug, cardioversion, catheter ablation)

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
300
Inclusion Criteria
  1. Patients with Atrial fibrillation (20~80 years old)
  2. patients with Acute stroke within 7 days
  3. LA diameter < 55mm
  4. patients possible to anticoagulation and anti arrhythmic drug
  5. NIHSS score ≤12
Exclusion Criteria
  1. Hemorrhagic transformation

  2. Large cerebral lesion or cerebellar lesion (more than 1/3 of MCA area and 1/2 of ACA area, 1/2 of PCA area, 1/2 of cerebellar area)

  3. active internal bleeding

  4. Impossible to anticoagulation or anti arrhythmic drug

  5. Valvular AF (MA> GII, Mechanical valve, Mitral valve replacement)

  6. LV ejection fraction < 30%

  7. Structural cardiac disease

  8. Catheter ablation history for AF, Cardiac surgery

  9. Already prescribed anti arrhythmic drugs

  10. With severe medical disease

  11. Expected survival < 1year

  12. Severe alcoholics, drug addiction

  13. Contraindication to MRI 15. Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
acute stroke with AF1 year

Long term outcome of rhythm control in patients with acute stroke with AF related to all cause morality, hospital admission, recurrence rate of stroke, major adverse cardiac events

recurrence of silence stroke1 year

Adverse events after anticoagulation or anti arrhythmic drug, recurrence rate after RFCA on AF in patients with stroke, adverse events after RFCA, recurrence rate of silence stroke or clinical stroke

recurrence of AF after rhythm control1 year

Adverse events after anticoagulation or anti arrhythmic drug, recurrence rate after RFCA on AF in patients with stroke, adverse events after RFCA, recurrence rate of silence stroke or clinical stroke

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Severance Cardiovascular Hospital, Yonsei University Health System

🇰🇷

Seoul, Korea, Republic of

Severance Cardiovascular Hospital, Yonsei University Health System
🇰🇷Seoul, Korea, Republic of
Hui-Nam Pak, M.D., Ph.D.
Contact
82-2-2228-8459
hnpak@yuhs.ac

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.